Siemoneit K, da Silva Cardoso M, Wölpl A, Epple S, Wintersinger H, Koerner K, Kubanek B
German Red Cross Blood Bank, Ulm.
Ann Hematol. 1994 Sep;69(3):129-33. doi: 10.1007/BF01695693.
In this study we tested the seroreactivity of 223 selected anti-HCV-reactive blood donors to the human B-cell epitope N-VYLLPR-C (C34-39) of the hepatitis C virus core antigen. The epitope was recently identified and characterized by the human monoclonal IgG antibody Ul/F10 and is located within the amino acid residues 34-39 of the aminoterminal core region. The blood donor sera were selected from anti-HCV ELISA (Ortho, 2nd generation)-reactive samples. Sixty-seven of these sera were further reactive in RIBA (Ortho, 2nd generation). According to their RIBA pattern, these samples were divided into four groups. Samples in the first group (n = 18) reacted to all four recombinant HCV antigens. The samples of the second (n = 9) and third group (n = 8) reacted to c22-3/c33c and c22-3/c100-3, respectively. Sera from group 4 (n = 32) showed a RIBA indeterminate pattern with reactivity only to c22-3. All 223 samples were analyzed for anti-C34-39 antibodies by ELISA, and the 67 RIBA-reactive samples were additionally tested for the presence of HCV RNA by RT/PCR. In groups 1 and 2, over 80% of the samples showed anti-C34-39 reactivity which was restricted to the IgG1 isotype. In contrast, in groups 3 and 4, antibodies to the epitope C34-39 were detected in less than 10% of the samples. Interestingly, the anti-C34-39 response correlates with the presence of HCV RNA; 95.5% of the samples had coincident results in all subgroups. None of the RIBA-negative sera showed a specific seroreaction to the C34-39 peptide.
在本研究中,我们检测了223名经筛选的抗丙型肝炎病毒(HCV)反应性献血者对丙型肝炎病毒核心抗原的人B细胞表位N - VYLLPR - C(C34 - 39)的血清反应性。该表位最近由人单克隆IgG抗体Ul/F10鉴定和表征,位于氨基末端核心区域的氨基酸残基34 - 39内。献血者血清选自抗HCV ELISA(Ortho,第二代)反应性样本。其中67份血清在重组免疫印迹法(RIBA,Ortho,第二代)中进一步呈反应性。根据其RIBA模式,这些样本被分为四组。第一组样本(n = 18)对所有四种重组HCV抗原均有反应。第二组(n = 9)和第三组(n = 8)样本分别对c22 - 3/c33c和c22 - 3/c100 - 3有反应。第四组(n = 32)血清呈现RIBA不确定模式,仅对c22 - 3有反应。通过ELISA分析了所有223份样本中的抗C34 - 39抗体,并通过逆转录/聚合酶链反应(RT/PCR)对67份RIBA反应性样本额外检测了HCV RNA的存在情况。在第一组和第二组中,超过80%的样本显示抗C34 - 39反应性,且仅限于IgG1同种型。相比之下,在第三组和第四组中,仅不到10%的样本检测到针对表位C34 - 39的抗体。有趣的是,抗C34 - 39反应与HCV RNA的存在相关;所有亚组中95.5%的样本结果一致。所有RIBA阴性血清均未显示对C34 - 39肽的特异性血清反应。